PRESS RELEASE published on 06/05/2023 at 08:00, 3 years ago Biophytis to participate at the BIO International Convention in Boston from the 5th to the 8th of June
PRESS RELEASE published on 05/26/2023 at 08:00, 3 years ago Biophytis has filed with the French National Authority for Health (HAS) an application for Early Access Authorisation (EAA) for Sarconeos (BIO101) in the treatment of severe forms of COVID-1
PRESS RELEASE published on 05/25/2023 at 08:00, 3 years ago Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference
PRESS RELEASE published on 05/15/2023 at 08:00, 3 years 1 month ago Biophytis has filed with the EMA for authorization to initiate SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 05/11/2023 at 08:00, 3 years 1 month ago Successful capital increase for Biophytis with €2.3 million raised
PRESS RELEASE published on 05/10/2023 at 19:05, 3 years 1 month ago Biophytis launches a round of fundraising for approximately 2 million euros
PRESS RELEASE published on 05/09/2023 at 08:00, 3 years 1 month ago Biophytis has requested a pre-submission meeting with the EMA for the Marketing Authorisation of Sarconeos (BIO101) for the treatment of COVID-19
PRESS RELEASE published on 05/02/2023 at 08:00, 3 years 1 month ago Biophytis strengthens its management team
PRESS RELEASE published on 04/28/2023 at 23:00, 3 years 1 month ago Biophytis announces receipt of Nasdaq Notice
PRESS RELEASE published on 04/19/2023 at 08:00, 3 years 2 months ago Biophytis regains compliance with NASDAQ minimum bid price requirement
Published on 06/22/2026 at 15:58, 3 minutes ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 31 minutes ago NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 1 hour 1 minute ago Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 14:01, 2 hours ago Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate
Published on 06/22/2026 at 14:00, 2 hours 1 minute ago Adcore Enters Strategic Partnership with TikTok as a Channel Sales Partner
Published on 06/22/2026 at 15:33, 27 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/22/2026 at 15:32, 28 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/22/2026 at 08:30, 7 hours 31 minutes ago Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
Published on 06/19/2026 at 19:33, 2 days 20 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 20 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 3 days 22 hours ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 3 days 22 hours ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
